Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

V-IMMUNE® for Primary Immunodeficiency: A Phase III Clinical Trial (VIP Study)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06954441
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:36.507393+00:00
Published At
2026-01-20T00:00:00+00:00
Record Updated At
2026-01-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Immunodeficiencies", "Primary Immunodeficiencies (PID)", "Agammaglobulinemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-20"
protocolSection.identificationModule.nctId
"NCT06954441"
protocolSection.identificationModule.officialTitle
"V-IMMUNE\u00ae for Primary Immunodeficiency: A Phase III Clinical Trial (VIP Study)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Immunodeficiencies (protocolSection.conditionsModule.conditions)
  • Primary Immunodeficiencies (PID) (protocolSection.conditionsModule.conditions)
  • Agammaglobulinemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.